Donoghoe Nicholas — SEC Form 4 filings
SEC reporting owner CIK 1762951. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-20 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 67,087 shares, $14,533,509 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 32,710 shares @ $250.00 ($8,177,500) in AbbVie Inc., filed 2026-08-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | EVP, CHIEF BUS/STRAT OFFICER | 9 | — | 4 legs · 67,087 sh · $14,533,509 | 20 |
Form 4 filings — Donoghoe Nicholas
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | AbbVie Inc. (ABBV) | Option exercise (M): 32,710 @ $79.02 · Sale (S): 32,710 @ $250 · Option exercise (M): 32,710 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 12,874 @ $232.08 | EDGAR |
| 2026-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 13,031 @ $0 · Grant/award (A): 4,632 @ $0 · Grant/award (A): 5,172 @ $0 · Grant/award (A): 6,222 @ $0 · Grant/award (A): 20,312 (derivative) @ $0 | EDGAR |
| 2025-08-07 | 4 | AbbVie Inc. (ABBV) | Sale (S): 3,234.17 @ $198.27 · Sale (S): 10,061 @ $198.59 | EDGAR |
| 2025-03-04 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 11,230 @ $205.02 | EDGAR |
| 2025-02-18 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 11,017 @ $0 · Grant/award (A): 4,520 @ $0 · Grant/award (A): 4,634 @ $0 · Grant/award (A): 5,174 @ $0 · Grant/award (A): 23,437 (derivative) @ $0 | EDGAR |
| 2024-03-22 | 4 | AbbVie Inc. (ABBV) | Sale (S): 21,082 @ $176.30 | EDGAR |
| 2024-03-01 | 4 | AbbVie Inc. (ABBV) | Tax withholding (F): 16,771 @ $178.99 | EDGAR |
| 2024-02-20 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 22,657 @ $0 · Grant/award (A): 6,042 @ $0 · Grant/award (A): 4,520 @ $0 · Grant/award (A): 4,634 @ $0 · Grant/award (A): 21,433 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1762951 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →